C-reactive protein: A physiological activator of interleukin 6 receptor shedding

被引:158
作者
Jones, SA
Novick, D
Horiuchi, S
Yamamoto, N
Szalai, AJ
Fuller, GM
机构
[1] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[3] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
[4] Tokyo Med & Dent Univ, Dept Microbiol, Tokyo 113, Japan
关键词
cytokines; interleukin; 6; soluble receptors; acute phase proteins; inflammation;
D O I
10.1084/jem.189.3.599
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The soluble interleukin 6 receptor (sIL-6R) circulates at elevated levels in various diseases. This suggests that inflammatory mediators control sIL-6R release. Through examination of human neutrophils, it was found that the acute phase reactant C-reactive protein (CRP) activates a threefold increase in sIL-6R production. Maximal release occurred after 30-60 min exposure to CRP (50 mu g/ml), and was mimicked by peptides corresponding to amino acid residues 174-185 and 201-206 of native CRP. A third peptide fragment (77-82) had no effect. Differential mRNA splicing did not account far the CRP-mediated release of sIL-6R, since this isoform was not detected in conditioned media. Furthermore, stimulation of neutrophils with CRP or with peptides 174-185 or 201-206 promoted a loss of membrane-bound IL-6R, suggesting release by proteolytic shedding. The metalloprotease inhibitor TAPI had only a marginal effect on CRP-mediated sIL-6R release, suggesting that shedding occurs via a mechanism distinct from that previously reported. It well established that IL-6 stimulates the acute phase expression of CRP. Our current findings demonstrate a novel relationship between these two mediators, since CRP may affect IL-6-mediated inflammatory events by enabling formation of the sIL-6R/IL-6 complex.
引用
收藏
页码:599 / 604
页数:6
相关论文
共 45 条
[1]   Transgenic mice expressing rabbit C-Reactive protein exhibit diminished chemotactic factor-induced alveolitis [J].
Ahmed, N ;
Thorley, R ;
Xia, DY ;
Samols, D ;
Webster, RO .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) :1141-1147
[2]   Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors [J].
Arribas, J ;
Coodly, L ;
Vollmer, P ;
Kishimoto, TK ;
RoseJohn, S ;
Massague, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11376-11382
[3]   Activation of alveolar macrophage TNF and MCP-1 expression in vivo by a synthetic peptide of C-reactive protein [J].
Barna, BP ;
Thomassen, MJ ;
Zhou, P ;
Pettay, J ;
SinghBurgess, S ;
Deodhar, SD .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (03) :397-402
[4]  
Bennett TA, 1996, J IMMUNOL, V156, P3093
[5]   Interleukin-6 stimulates neutrophil production of platelet-activating factor [J].
Biffl, WL ;
Moore, EE ;
Moore, FA ;
Barnett, CC ;
Silliman, CC ;
Peterson, VM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (04) :569-574
[6]  
Cichy J, 1997, J IMMUNOL, V159, P5648
[7]  
Desgeorges A, 1997, J RHEUMATOL, V24, P1510
[8]   EFFECTS OF C-REACTIVE PROTEIN ON HUMAN NEUTROPHIL GRANULOCYTES CHALLENGED WITH N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE AND PLATELET-ACTIVATING FACTOR [J].
FILEP, J ;
FOLDESFILEP, E .
LIFE SCIENCES, 1989, 44 (08) :517-524
[9]   ROLE OF INTERLEUKIN-6 IN REGULATING SYNTHESIS OF C-REACTIVE PROTEIN AND SERUM AMYLOID-A IN HUMAN HEPATOMA-CELL LINES [J].
GANAPATHI, MK ;
MAY, LT ;
SCHULTZ, D ;
BRABENEC, A ;
WEINSTEIN, J ;
SEHGAL, PB ;
KUSHNER, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (01) :271-277
[10]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314